Market Research ReportDec 2, 2022

Fluoroscopy and Mobile C Arms Market

Fluoroscopy and Mobile C Arms Market Research Report: Size, Share, Trend Analysis Device Type (Fluoroscopy Systems, Mobile C-Arms), Application (Gastrointestinal, Orthopedics, Pain Management and Trauma, Cardiovascular, Neurology, Urology), End User (Hospitals and Clinics, Diagnostic Centers, Research and Academic Institutes, End User_Others) and By Region (Asia Pacific, South America, Europe, North America, Middle East and Africa) - Growth Outlook & Industry Forecast To 2023

Vertical: HealthcareBase Year: 2017

Book Demo

Executive Summary

Fluoroscopy and Mobile C Arms Market — Snapshot

Market Size (2017)
$2.23B
Projected (2023)
$2.95B
CAGR (2015–2023)
4.9%
Key Players
14+

Fluoroscopy is a medical imaging technique which displays multiple x-rays to generate real-time images or a video of the patient’s body. Fluoroscopy and mobile c-arms systems are used in wide range of interventional radiological procedures, especially in the treatment of conditions such as spinal cord injury, varicose veins, peripheral artery disease (PAD), pulmonary embolism, deep vein thrombosis, abdominal aortic aneurysms, and other chronic conditions. The major factors propelling the growth of thie global fluoroscopy and mobile c-arms market include the growing prevalence of chronic diseases, increasing geriatric population, and growing adoption of fluoroscopy in orthopedic and neurological procedures.

The global fluoroscopy and mobile c-arms market was valued at USD 2,234.3 million in 2017, and the market is estimated to grow at USD 2.951.4 million in 2023. In 2017, the Americas accounted for the largest market share of 44.7% with a market value of USD 997.7 million, followed by Europe with a market value of USD 734.4 million in 2017.

The global fluoroscopy and mobile c-arms market has been segmented into device type, application, and end user.

On the basis of device type, the market has been segmented into fluoroscopy systems and mobile c-arms. The fluoroscopy systems segment was the largest market segment, by device type with a market value of USD 1,390.2 million in 2017.

By application, the market has been segmented into gastrointestinal, orthopedics, cardiovascular, pain management and trauma, neurology, urology, and others. The gastrointestinal segment was the largest market segment, by application with a market value of USD 571.7 million in 2017.

Based on end user, the market has been segmented into hospitals & clinics, diagnostic centers, research and academic institutes, and others. The hospitals & clinics segment was the largest market segment, by end user with a market value of USD 896.0 million in 2017.

Key Insight

The Fluoroscopy and Mobile C Arms Market market is projected to grow at a CAGR of 4.9% from 2015 to 2023.

Market Performance Trend

Historical performance and future projections (2020–2030, USD Billion)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Scope & Coverage

What this report covers

Geographic Coverage: This analysis covers 5 regions: Asia Pacific, South America, Europe, North America, Middle East and Africa.
Market Segmentation: The market is analyzed across 2 segments: Fluoroscopy Systems, Mobile C-Arms. Forecasts are provided for each segment from 2015 to 2023.
Competitive Landscape: 14 leading companies are profiled, covering market positioning, strategies, and recent developments.

Market Size (USD Mn)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Overview

Fluoroscopy and Mobile C Arms Market — Growth Trajectory

Fluoroscopy and mobile c-arms are imaging techniques used in a range of diagnostic and therapeutic procedures. The fluoroscopy technique provides X-ray imaging which is useful in examining the internal structure and functions of the patient’s body. This imaging technique is generally used in image-guided surgeries, general radiology, and interventional radiology. The C-arm equipment is based on X-ray technology and is mostly used in vascular surgeries, traumatology, cardiology, and orthopedics. The name of the equipment “C-arm” is derived from the C-shaped arm used to connect the X-ray source and X-ray detector to one another.

Fluoroscopy and Mobile C Arms Market — Growth Trajectory

Fluoroscopy Systems

Mobile C-Arms

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Size Trend (USD Mn)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Dimensions

How this market is segmented

Device Type is broken down into: Fluoroscopy Systems, Mobile C-Arms.
Application is broken down into: Gastrointestinal, Orthopedics, Pain Management and Trauma, Cardiovascular, Neurology, Urology, Others.
End User is broken down into: Hospitals and Clinics, Diagnostic Centers, Research and Academic Institutes, End User_Others.

Geographic Analysis

Regional market breakdown

Asia Pacific market size reached $326.00M in 2015 and is projected to reach $470.30M by 2023, growing at a CAGR of 4.7%.
South America market size reached $124.00M in 2015 and is projected to reach $186.20M by 2023, growing at a CAGR of 5.2%.

Europe market size reached $658.00M in 2015 and is projected to reach $942.40M by 2023, growing at a CAGR of 4.6%.
North America market size reached $767.40M in 2015 and is projected to reach $1.16B by 2023, growing at a CAGR of 5.3%.
Middle East and Africa market size reached $136.80M in 2015 and is projected to reach $188.80M by 2023, growing at a CAGR of 4.1%.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Research Methodology

Fluoroscopy and Mobile C Arms Market — How We Researched This Market

Wantstats analysis is based on interviews with industry experts who offer insight into the market structure, market segmentation, technology assessment, competitive landscape (CL), market penetration, as well as the emerging trends. Besides primary interviews (~80%) and secondary research (~20%), their analysis is based on years of professional expertise in their respective industries. Our analysts also predict where the market will be headed in the next five to 10 years, by analyzing historical trends and the current market position. Furthermore, the varying trends in segments and categories in each region are studied and estimated based on primary and secondary research.

1.1 Primary Research

Extensive primary research was conducted to gain a deeper insight into the market and industry performance. For this report, we have conducted primary surveys (interviews) with the key level executives (VPs, CEOs, marketing directors, and business development managers, among others) of the major players active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed in the next five to 10 years.

1.1 Secondary Research

Secondary research was mainly used to collect and identify information useful for an extensive, technical, market-oriented, and commercial study of the global fluoroscopy and mobile c-arms market. It was also used to obtain key information about major players, market classification and segmentation according to industry trends, and developments related to the market and technology. For this study, analysts have gathered information from various credible sources such as the American College of Radiology, Center for Disease Control and Prevention, United States Food and Drug Administration, Expert Interviews, European Society of Radiology, International Society of Radiology, Radiological Society of North America, American Board of Radiology, Mexican Radiology and Imaging Society, Cardiovascular and Interventional Radiological Society of Europe, French Society of Radiology, Indian Radiology and Imaging Association, Japan Radiological Society, Annual Reports, SEC filings, Research Journals, White Papers, Corporate Presentations, Company websites, Wantstats Analysis, and paid databases.

1.1 Market Size Estimation

Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets of the overall global fluoroscopy and mobile c-arms market. The key players in the market were identified through secondary research, and their market contributions in different applications across the globe were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to arrive at the final quantitative and qualitative data. This data has been consolidated, and detailed inputs and analysis from Wantstats added before being presented in this report. The following figure shows an illustrative representation of the overall market size estimation process employed for this study.

Base Year
2017
Historical Period
2015 – 2016
Forecast Period
2018 – 2023
Primary Interviews
150+

Research Process

Historical data (2015–2017) and forecast period (2017–2023)

Problem Definition

Market scoping
Objective setting
Framework design

Secondary Research

Literature review
Data mining
Trend analysis

Primary Research

Expert interviews
Field visits
Surveys

Data Analysis

Quantitative modeling
Statistical testing
Validation

Insights & Reporting

Synthesis
Recommendations
Visualization

Research Depth

Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.

Historical vs. Forecast Data

Historical (observed)

Forecast (modelled)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Competitive Landscape & Porter's Five Forces

Fluoroscopy and Mobile C Arms Market — Competitive Analysis

There are few dominating players operating in the global fluoroscopy and mobile c-arms market and these players generate maximum market share. Additionally, there are other small and medium scale players present in the market. Moreover, the launch of new products has assisted some major players to gain a competitive advantage in the market.

GE Healthcare (US) is a prominent player in the field of imaging devices. The firm accounted for 20.4% share in 2017. The key reason for its growth is its wide range of products and wide application areas. The company has a broad portfolio of fluoroscopy and mobile c-arms systems. This increase in product approvals and launches would support the company’s growth in the fluoroscopy and mobile C-arms market in the coming years. For instance, in August 2016, GE Healthcare launched the OEC Elite MiniView C-arm, a new imaging system designed to change the mini C-arm experience for surgeons.

Siemens (Germany) accounted for approximately 18.4% of the fluoroscopy and mobile c-arms market. Moreover, the company focuses on organic growth strategies to increase its market share. Additionally, the company is actively engaged in strategic partnerships to increase its market presence. For instance, in August 2017, the company formed a strategic partnership with the Medical University of South Carolina (MUSC). Additionally, in July 2015, Siemens signed a new contract with Inpeco, a market leader in the field of total laboratory automation.

Koninklijke Philips N.V. (Philips Healthcare) (Netherlands) contributed to approximately 13.5% of the fluoroscopy and mobile c-arms market in 2017. The company offers a wide range of products for fluoroscopy systems along with c-arm systems. The firm concentrates on strategic partnerships to increase its presence and market share. Additionally, the company is involved in the continuous development of innovative products. Recently, in February 2019, the company announced the launch of Philips Zenition, its new mobile C-arm imaging platform. Moreover, in April 2018, the company announced the US FDA clearance of ProxiDiagnost N90, a digital radiography-fluoroscopy system.

Hitachi Ltd (Japan) accounted for the fourth largest spot with 11.7% of the market share. The company focuses on merger and acquisition activities to maximize its market share. For instance, in December 2016, Hitachi acquired 75% shares of Kurt & Kurt, making it a consolidated subsidiary of the company.

Other firms accounted for 12.4% market share in 2017, that includes companies such as DSM Imaging, Omega Medical Imaging, LLC, Carestream Health, Aurora Healthcare US Corp, and Dilon Technologies, Inc, among others.

Bargaining Power of Suppliers

The bargaining power of suppliers in the global fluoroscopy and mobile C-arms market is moderate. In this market, the suppliers are laboratory instruments manufacturers and accessories manufacturers. There are many major and small manufacturers involved in providing various imaging equipment that are used in clinical research, new drug development and for the diagnosis of diseases. Most of the major players are investing huge money in R&D and new product development. Innovation and advanced products give an edge to suppliers. Major brands have a strong presence and brand value in the market while many medium and small players are also providing the same products at different pricing. Grey market of products is affecting the bargaining power of suppliers. Quality of the products are the key factors that directly affect the bargaining power of suppliers. Moreover, the larger the number of suppliers in the market lower is the bargaining power of the supplier. The innovation and cost-effective products give an edge to suppliers to increase their market and create brand loyalty among the customer.

Bargaining Power of Buyers

The bargaining power of the buyer in the global fluoroscopy and mobile C-arms market is high. Bargaining power of the buyer can define by a number of buyers, switching cost from one seller to other, and availability of alternative products. If the number of buyers for fluoroscopy and mobile C-arms products is high the bargaining power will be low. There are different research centers, hospitals and academic industries using imaging diagnostic devices, so the demand for the product is high. The presence of a large number of suppliers and low switching cost increases the bargaining power of the buyer. The threat of backward integration is low in this market.

Threat of New Entrants

The threat of new entrants in the global fluoroscopy and mobile C-arms market is moderate. The global fluoroscopy and mobile C-arms market is growing rapidly due to the growing geriatric population and increasing number of sports injuries worldwide, rising R&D funding for the development of new imaging device, increasing demand for fluoroscopy by the hospitals. The companies involved in the mergers and acquisitions and rapid product launches are generating a huge amount of profit and influencing the potential companies to enter into this market.

The specialist knowledge or expertise related to product development and the huge capital required for the development of fluoroscopy and mobile C-arms products acts as an entry barrier for the new players. Brand loyalty and tough competition from existing companies also prohibit the entry of new players.

Further, several small and medium-size companies are creating their space and trying to capture the market share which mostly untouched by major players. Easy distribution and undifferentiating product are increasing the threat of new entrants in the global fluoroscopy and mobile C-arms market.

Threat of Substitutes

The threat of substitutes in the global fluoroscopy and mobile C-arms market is low. The innovation and launch of new imaging diagnostics systems for the diagnosis of vascular, cardiological, and orthopedic anomalies are increasing the threat of substitution for existing products. The customers tend to select the product according to their need and which provide the best results. The other factors that increase the threat of substitutes are low brand loyalty, increasing the price of the product and low switching cost. So, the companies are focusing on developing high-quality and cost-effective products as per the market need to decrease the threat of substitute.

Intensity of Rivalry

The intensity of rivalry in the global fluoroscopy and mobile C-arms market is moderate. The rising demand for imaging techniques and diagnostic products by the end user such as hospitals and research academies are contributing to the increase in rivalry among the companies to capture a large market. Also, the increase in similar types of product offered by different companies increases the competition among the companies. The increase in the number of players decreases the profit share for each company and results to increase the intensity of competition in the respective market.

Quantitative Analysis

Regional Breakdown

Regional market breakdown for Fluoroscopy and Mobile C Arms Market.

Regional Market Size (USD Mn)

Market estimates by geography (2023)

USD Mn

InsightNorth America leads with $1.16B by 2023.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Regional Market Data

REGION	2015	2017	2023	CAGR	SHARE
Asia Pacific	$326.00M	$378.50M	$470.30M	4.7%	16%
South America	$124.00M	$157.50M	$186.20M	5.2%	6%
Europe	$658.00M	$818.50M	$942.40M	4.6%	32%
North America	$767.40M	$960.80M	$1.16B	5.3%	39%
Middle East and Africa	$136.80M	$169.10M	$188.80M	4.1%	6%
Total	$2.01B	$2.48B	$2.95B	4.9%	100%

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Segment Revenue (2023)

Fluoroscopy Systems

Mobile C-Arms

00.511.52

Fluoroscopy Systems61%
Mobile C-Arms39%

Total Market Size

$2.95B

Market by Segment (2023)

APPLICATION	REVENUE ($B)	GROWTH RATE	MARKET PENETRATION
Fluoroscopy Systems	$1.80B	4.7%	61%
Mobile C-Arms	$1.15B	5.2%	39%

* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Empower your Business
with Insights

Save over 20% on
Annual Subscription

Subscribe now

Book a demo

See plans for professionals or small and medium businesses.

Analytics

Fluoroscopy and Mobile C Arms Market — Key Findings

Analytical insights on Fluoroscopy and Mobile C Arms Market covering market dynamics, competitive landscape, and strategic outlook.

Key Analytical Findings

The Fluoroscopy and Mobile C Arms Market market is projected to reach $2.95B by 2023, growing at 4.9% CAGR. The Fluoroscopy Systems segment holds the largest share.

Market Dynamics

Fluoroscopy is a type of medical imaging technique which uses x-rays to obtain real-time moving images of the internal structures of a patient through the use of a fluoroscope. Fluoroscopic systems and mobile c-arms are used for a range of diagnostic and surgical procedures such as vascular orthopedics, gastrointestinal diseases, neurological disorders, pain management, and in certain emergency procedures. Moreover, mobile c-arms are extensively used as an intraoperative imaging solution in minimally invasive diagnostic and surgical procedures such as localization of implants. The rising popularity of minimally invasive procedures is spurring the demand for fluoroscopic and mobile c-arms systems. Also, the growing geriatric population coupled with increasing prevalence of chronic diseases and rising adoption of fluoroscopy in orthopedic and neurological procedures are likely to boost the growth of the global fluoroscopy and c-arms market over the forecasted period. Despite the drivers, factors such as high cost associated with fluoroscopic and mobile c-arms systems, the risk of radiation, and the presence of substitutes could hamper the growth of the market.

Market Drivers

Generally, the older population is more susceptible to diseases as the immune system becomes weak with aging. Moreover, surgical procedures in old people require proper monitoring, as a slight error in the procedure could cause severe damage to the old patient. Moreover, owing to the high risk of surgical complications, image-guided surgeries are mostly preferred in the geriatric population. In recent years, the population of old people has increased significantly which is likely to contribute to the market growth. According to Statistics Canada, in 2016, there was about 5.9 million senior population living in Canada. Likewise, as per the data by the US Census Bureau, in 2015, there were about 47.8 million people aged 65 and older in the US. Apart from growing geriatric population, the prevalence of several chronic diseases such as cardiovascular diseases, osteoarthritis, epilepsy, and nervous system diseases is rising tremendously which is thereby boosting the demand for fluoroscopy and mobile c-arms equipment for diagnosis and minimally invasive surgical procedures. As per the data by the American Heart Association, in 2017, nearly 92.1 million American adults were living with some form of cardiovascular diseases or the after-effects of stroke in the US.

Also, according to the Centers for Disease Control and Prevention (CDC), in 2015, 1.2% of the total US population had active epilepsy. Fluoroscopy systems are used in operating rooms for visualizing kidney drainage, abdominal and thoracic aortic aneurysm repair, percutaneous valve replacements, cardiac surgery, vascular surgery, gastroenterology, neurostimulation, orthopedics, pain management, and neurology procedures. Thus, the growing geriatric population along with the rising prevalence of chronic diseases is anticipated to fuel the growth of global fluoroscopy and mobile c-arms market.

Market Opportunities

In recent years, various new technologies in fluoroscopy have increased accuracy in diagnosis to a great extent. Likewise, the increasing adoption of fluoroscopy and mobile c-arms systems by many prominent players has led to the development of advanced products. For instance, in March 2018, Philips Healthcare received the US FDA 510 (k) clearance to market ProxiDiagnost N90, its premium digital radiography, and a nearby fluoroscopy system. Similarly, in August 2017, GE Healthcare launched the OEC Elite MiniView C-arm, a new imaging system designed to change the mini C-arm experience for surgeons. Also, in October 2015, Hologic launched the Fluoroscan InSight FD Mini C-Arm extremities imaging system. Additionally, in November 2014, Toshiba America Medical Systems Inc.'s Kalare R/F digital X-ray system with a flat panel detector (FPD) received the US FDA clearance. Likewise, Sonialvision G4 universal digital R/F table system by Shimadzu Medical Systems USA received the US FDA approval in April 2014. Therefore, increasing technological advancements in the field of fluoroscopy are anticipated to be a huge opportunity for market players in the global fluoroscopy and mobile c-arms market.

Market Restraints

The high cost of fluoroscopy and mobile c-arms systems may negatively affect market growth. High instrument cost along with huge maintenance cost is not affordable by all users, especially in developing regions. The price of these devices varies according to the type of model and company. The average cost of a fluoroscopic system ranges from USD 4,15,000 to 1,150,00. Also, the Siemens’ Arcadis Avantic model costs about USD 90,000 to USD 1,00,000. Similarly, Siemens’ Compact L and Philips’ BV Libra Endura cost about USD 50,000 to USD 80,000. Additionally, the cost of repair and decontamination procedures increases the overall maintenance cost. Thus, this factor may hamper the growth of the global fluoroscopy and mobile c-arms market.

Market Challenges

Recently, the use of refurbished devices is on a continuous rise due to the improving reliability of refurbished devices along with the low cost as compared to new devices. For instance, the refurbished Ziehm 700 instrument costs about USD 19,000 to USD 25,000. The low-cost factor, in turn, is affecting the sales rate of new devices in emerging markets, where the purchasing power of the buyer is less. Additionally, the low replacement rate of fluoroscopy devices can also affect the market growth of fluoroscopy and mobile c-arms.

Investment Opportunities

Investment in the market highlight the growth parameters of the industry. Patents and approvals, reimbursement policies, the growth of the imaging diagnostic equipment, treatment method for numerous diseases, and its associated complications define the potential of the market. There is a huge demand or potential in the fluoroscopy and mobile C-arms market and the most suitable treatment regimen is decided based on these imaging techniques and diagnostic solutions such as X-ray, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and Positron Emission Tomography (PET) among others.

Innovation and development in the fluoroscopy and mobile C-arms market benefit both the manufacturers as well as investors, to make huge profits. Therefore, a revolution in technologies for new product offering will provide investment opportunities in the future. Moreover, the C-arm equipment is also based on X-ray technology and frequently used in vascular surgeries, traumatology, cardiology, and orthopedics. The name “C-arm” is derived from the C-shaped arm used to connect the X-ray source and X-ray detector to one another.

· Increasing use of refurbished devices affecting new sales

The trend for the adoption of refurbished devices are on the rise, with the improving reliability of these devices, combined with the low cost as compared to new devices, the use of refurbished devices is on a continuous rise. This, in turn, is affecting the sales rate of new devices in the emerging markets, where the purchasing power is less. Moreover, the low replacement rate of fluoroscopy devices is also limiting the global fluoroscopy devices market growth.

With the increasing prevalence of cardiovascular and orthopedic disorders along with the development of novel imaging devices, there would be increasing opportunities for investment in this sector as demand for the novel diagnostic systems will boost the market in the future.

The increased funding and investment by government and private organization will boost the fluoroscopy and mobile C-arms market. There are various existing players imaging system manufacturing for the above-mentioned indications, and there are many more, there can be innovation done in the existing product like the imaging techniques, product size and powers source can be modified. Another investment opportunity is to manufacture the parts and components for diagnostic devices, with add-on features. Companies can make a business from OEM that manufacture diagnostic components. So, this may reduce the cost of manufacturing.

Strategic Outlook and Future Directions

Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.

Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.

Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.

Market Value by Segment (2023)

Value (USD Mn)

Fluoroscopy Systems

Mobile C-Arms

Companies

Key companies profiled in Fluoroscopy and Mobile C Arms Market

Profiles of 104 companies operating in the Fluoroscopy and Mobile C Arms Market market, including revenue, employee count, and market positioning where available.

Region

Industry

Founded Year

Showing 104 of 104 companies

DMS Group

Healthcare

Company Headquarters: France Founded: 1974 Workforce: 134 Company Working: DMS Group specializes in high technology solutions that assist the diagnostic medical imaging community. It is involved in manufacturing and distributing imaging systems dedicated to conventional and digital radiology as well as bone densitometry. DMS Group constitutes two subsidiaries, namely, DMS and Apelem.

Ziehm Imaging GmbH

Company Headquarters: Florida, US Founded: 1972 Company Working: Ziehm Imaging GmbH develops mobile fluoroscopic imaging products for interventional radiology and surgery applications in the US and internationally. It offers mobile C-arms for a range of clinical applications and considers mobile X-ray imaging to be its core competency.

Villa Sistemi Medicali Spa

Healthcare

Company Headquarters: Italy Founded: 1958 Company Working: Villa Sistemi Medicali Spa designs, manufactures, and markets diagnostic radiological systems for dental and medical applications. The company offers R/F systems and tilting tables, general and digital radiography rooms, mammography units, portable flat panel detectors, and mobile fluoroscopy and radiography systems, among others.

Allengers Medical Systems

Healthcare

Company Headquarters: Chandigarh, India Founded: 1987 Company Working: Allengers Medical Systems manufactures and exports a wide range of medical diagnostic equipment comprising X-ray systems, C-arms, and cathlabs, among others. The company constitutes a wide array of products from the radiology, cardiology, and neurology fields. It has a presence in more than 70 countries worldwide.

Shimadzu Corporation

United States, North America

Novavax, I

Novavax, Inc.

Healthcare

Company Headquarters: Maryland, US Founded: 1987 Workforce: ~2,500 Company Working: Novavax, Inc. is a biotechnology company that commercializes and develops vaccines to prevent a wide range of infectious diseases. It designs recombinant nanoparticle vaccine technology that produces a strong immune response against a variety of pathogens. It is partnered with leading biopharma organizations, government agencies, research institutions, and foundations, namely the Coalition for Epidemic Preparedness Innovations (US), the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (US), the Serum Institute of India Pvt. Ltd. (India), SK Bioscience (South Korea), CPL Biological (India), and Takeda Pharmaceuticals (US). It has seven research and manufacturing facilities. It has presence in regions namely North America, Europe, and the Middle East and Africa

Page 1 of 18

…

Go to page

About the Author

Healthcare Research Team

Healthcare

Our healthcare desk at Wantstats is staffed by a mix of clinical-market analysts and a senior researcher who track drug approvals, device launches, and provider economics as they happen — not just at reporting time. Every figure in this report is checked against primary interviews, regulatory filings, and our own proprietary datasets before it goes to print.

Similar Reports

View all

HealthcareJul 31, 2026

Stoma Ostomy Care Market

HealthcareJul 31, 2026

Ready-to-eat Popcorn Market

HealthcareJul 31, 2026

Organoids and Spheroids Market

Powering the world's best teams.
From next-gen startups to established enterprises.

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Fluoroscopy and Mobile C Arms Market

Fluoroscopy and Mobile C Arms Market Research Report: Size, Share, Trend Analysis Device Type (Fluoroscopy Systems, Mobile C-Arms), Application (Gastrointestinal, Orthopedics, Pain Management and Trauma, Cardiovascular, Neurology, Urology), End User (Hospitals and Clinics, Diagnostic Centers, Research and Academic Institutes, End User_Others) and By Region (Asia Pacific, South America, Europe, North America, Middle East and Africa) - Growth Outlook & Industry Forecast To 2023

Starting from

$4,950

Fluoroscopy and Mobile C Arms Market

Key Insight

Market Performance Trend

Market Scope & Coverage

What this report covers

Fluoroscopy and Mobile C Arms Market — Growth Trajectory

Market Size Trend (USD Mn)

Market Dimensions

How this market is segmented

Geographic Analysis

Regional market breakdown

Problem Definition

Secondary Research

Primary Research

Data Analysis

Insights & Reporting

Research Depth

Historical vs. Forecast Data

Competitive Landscape & Porter's Five Forces

Fluoroscopy and Mobile C Arms Market — Competitive Analysis

Regional Market Data

Segment Revenue (2023)

Segment Market Share

Market by Segment (2023)

Save over 20% onAnnual Subscription

Key Analytical Findings

Market Dynamics

Market Drivers

Market Opportunities

Market Restraints

Market Challenges

Investment Opportunities

Strategic Outlook and Future Directions

Market Value by Segment (2023)

About the Author

Healthcare Research Team

Market Performance Trend

Fluoroscopy and Mobile C Arms Market — Growth Trajectory

Market Size Trend (USD Mn)

Market Dimensions

How this market is segmented

Geographic Analysis

Regional market breakdown

Problem Definition

Secondary Research

Primary Research

Data Analysis

Insights & Reporting

Research Depth

Historical vs. Forecast Data

Competitive Landscape & Porter's Five Forces

Fluoroscopy and Mobile C Arms Market — Competitive Analysis

Regional Market Data

Segment Revenue (2023)

Segment Market Share

Market by Segment (2023)

Save over 20% onAnnual Subscription

Key Analytical Findings

Market Dynamics

Market Drivers

Market Opportunities

Market Restraints

Market Challenges

Investment Opportunities

Strategic Outlook and Future Directions

Market Value by Segment (2023)

About the Author

Healthcare Research Team

Save over 20% on
Annual Subscription

Save over 20% on
Annual Subscription